Home | Business News | Browse by Publication | B | Business Wire

Cytogen and Progenics Initiate Phase I Clinical Testing of New Therapeutic Prostate Cancer Vaccine.

Publication: Business Wire
Publication Date: 19-DEC-02
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Business Editors/Health/Medical Writers

BIOWIRE2K

PRINCETON, N.J. & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Dec. 19, 2002

The PSMA Development Company LLC, a joint venture of Cytogen Corporation (Nasdaq: CYTO) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced the initiation of a Phase I clinical trial for a novel prostate cancer vaccine directed against prostate-specific membrane antigen, or PSMA.

This vaccine combines the PSMA cancer antigen with an immune stimulant to induce an immune response against prostate cancer cells as foreign and to eliminate them. The genetically engineered PSMA vaccine generated potent immune responses in preclinical animal testing.

"This clinical trial is the first of a series designed to elicit potent and durable immune responses to PSMA, a protein that is highly expressed on prostate cancer cells," said Howard I. Scher, M.D., chief, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center in New York City. "The new vaccine contains a recombinant PSMA protein that mimics the form of PSMA found on the surface of prostate cancer cells. As PSMA is uniquely found on the surface of prostate cancer cells and its expression increases with disease progression, it provides a highly attractive target...

Read the FULL article now - Try Goliath Business News - FREE!   
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News - Free for 3 Days!
Tell Me More   Terms and Conditions

Get Goliath Business News for 1 year - Just $99 (Save 65%)
Tell Me More   Terms and Conditions

Already a subscriber? Log in to view full article



More articles from Business Wire
ATA's ``Thursday Fun Fares''; Travel from Indianapolis to Phoenix, San..., December 19, 2002
Margaux Investment Management Group S.A. -- Is Contracted by FreeStar ..., December 19, 2002
Kansas Bureau of Investigation Deploys Best-of-Breed Security Solution..., December 19, 2002
Korean Semiconductor and Electronics Equipment Manufacturer Increases ..., December 19, 2002
Mutual of Enumclaw 0ffers Online Rating and Application for Business O..., December 19, 2002

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.